Novo Nordisk’s stock plunged Tuesday after the maker of diabetes and weight-loss drugs Ozempic and Wegovy said it expects sales to fall by a lot more than analysts projected.
Investors on Tuesday were dumping software and data-services stocks after Anthropic announced a new AI automation tool that ...
Follow all the latest U.S. market action for Wednesday here to see if investors can shrug off worries about how AI may damage the software sector.
Economists have expressed surprise and disappointment about the absence of any public remarks, which had been a routine part ...
Meanwhile, Novo Nordisk said Tuesday that fourth-quarter sales of Wegovy rose 17% on year at constant exchange rates to 21.86 billion Danish kroner ($3.46 billion), while sales of Ozempic rose 1% to ...
S&P 500, Nasdaq book worst day in two weeks as software stocks drag down market; AMD results on tap. Gold and silver rebound. U.S. stocks close lo ...
President Donald Trump on Tuesday signed a funding package into law just hours after the House of Representatives passed it ...
Super Micro’s revenue exploded to $12.7 billion as delayed orders finally materialized, but aggressive competition and rising ...
Airline stocks are priced cheaply relative to carriers’ expected earnings power. This isn’t unusual, in light of the industry ...
Of the many January indicators that investors look to for clues about the stock market’s direction, just one is statistically ...
13h
Bye-bye, Bahama Breeze: Olive Garden parent gives up on restaurant chain after years of struggles
The Bahama Breeze restaurant chain is closing, with half of the restaurants being shuttered and the other half converting to ...
Have an issue with your financial planner or looking for a new one? Email questions or concerns to picks@marketwatch.com.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results